FR1259M - Nouveau médicament notamment pour le traitement des infections dues a des staphylocoques. - Google Patents

Nouveau médicament notamment pour le traitement des infections dues a des staphylocoques.

Info

Publication number
FR1259M
FR1259M FR859498A FR859498A FR1259M FR 1259 M FR1259 M FR 1259M FR 859498 A FR859498 A FR 859498A FR 859498 A FR859498 A FR 859498A FR 1259 M FR1259 M FR 1259M
Authority
FR
France
Prior art keywords
staphylococci
treatment
new drug
infections due
infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR859498A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR850721A external-priority patent/FR1366724A/fr
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR859498A priority Critical patent/FR1259M/fr
Priority to FR881001A priority patent/FR23F/fr
Priority to GB274262A priority patent/GB938066A/en
Application granted granted Critical
Publication of FR1259M publication Critical patent/FR1259M/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/44Compounds with an amino radical acylated by carboxylic acids, attached in position 6
    • C07D499/48Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical
    • C07D499/50Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in beta-position to the carboxamido radical
    • C07D499/52Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in beta-position to the carboxamido radical by oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/192Radicals derived from carboxylic acids from aromatic carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
FR859498A 1961-01-25 1961-04-21 Nouveau médicament notamment pour le traitement des infections dues a des staphylocoques. Expired FR1259M (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR859498A FR1259M (fr) 1961-01-25 1961-04-21 Nouveau médicament notamment pour le traitement des infections dues a des staphylocoques.
FR881001A FR23F (fr) 1961-01-25 1961-12-05 Nouveau médicament notamment pour le traitement des infections dues a des staphylocoques.
GB274262A GB938066A (en) 1961-01-25 1962-01-24 New antibiotic compounds, processes for their preparation and therapeutic compositions incorporating them

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR850721A FR1366724A (fr) 1961-01-25 1961-01-25 Nouvel antibiotique et son procédé d'obtention
FR859498A FR1259M (fr) 1961-01-25 1961-04-21 Nouveau médicament notamment pour le traitement des infections dues a des staphylocoques.

Publications (1)

Publication Number Publication Date
FR1259M true FR1259M (fr) 1962-05-26

Family

ID=32947029

Family Applications (1)

Application Number Title Priority Date Filing Date
FR859498A Expired FR1259M (fr) 1961-01-25 1961-04-21 Nouveau médicament notamment pour le traitement des infections dues a des staphylocoques.

Country Status (1)

Country Link
FR (1) FR1259M (fr)

Similar Documents

Publication Publication Date Title
FR1444M (fr) Nouveau médicament notamment pour le traitement des irrégularités et des insuffisances ovariennes.
FR1994M (fr) Nouveau médicament notamment pour le traitement des manifestations dues a l'hyperlipémie ou a l'hypercholestérolémie.
FR2609M (fr) Nouveau médicament pour le traitement des infections staphylococciques et streptococciques.
FR1215M (fr) Nouveau médicament, notamment pour le traitement des troubles dus a une hyperestrogénie ou a une hypoandrogénie.
FR362M (fr) Nouveau médicament pour le traitement des infections staphylococciques et des salmonelloses.
FR365M (fr) Nouveau médicament pour le traitement des infections staphylococciques et streptococciques.
FR23F (fr) Nouveau médicament notamment pour le traitement des infections dues a des staphylocoques.
FR1259M (fr) Nouveau médicament notamment pour le traitement des infections dues a des staphylocoques.
FR2853M (fr) Nouveau médicament, notamment pour le traitement des infections dues a des staphylocoques.
FR3875M (fr) Nouveau médicament convenant notamment au traitement des infections tuberculeuses.
FR2193M (fr) Nouveau médicament pour le traitement des maladies infectieuses.
FR1272551A (fr) Nouveau procédé pour le traitement des cultures
FR363M (fr) Nouveau médicament pour le traitement des trypanosomoses, des salmonelloses et des infections pénicillo-résistantes.
FR2510M (fr) Nouveau médicament utilisable pour le traitement des infections staphylococciques et analogues.
FR385M (fr) Nouveau médicament pour le traitement des infections staphylococciques et analogues.
FR1979M (fr) Nouveau médicament notamment pour le traitement des manifestations dues a l'hyperaldostéronisme.
FR2413M (fr) Nouveau médicament notamment pour le traitement des manifestations inflammatoires et douloureuses.
CH409407A (de) Procédé pour la polymérisation des oléfines
FR1456M (fr) Nouveau médicament notamment pour le traitement des carences du corps jaune.
FR33F (fr) Nouveau médicament pour le traitement des infections staphylococciques et analogues.
FR3096M (fr) Nouveau médicament notamment pour le traitement des états d'adynamie.
FR1700M (fr) Nouveau médicament notamment pour le traitement des manifestations dues a l'hyperlipémie ou a l'hypercholestérolémie.
FR1729M (fr) Nouveau médicament notamment pour le traitement des manifestations inflammatoires et douloureuses.
FR1412M (fr) Nouveau médicament notamment pour le traitement des bronchites, pneumonies, collapsus cardiaques et défaillances cardiaques.
BE630069A (fr) Composition thérapeutique pour le traitement du parkinsonisme.